1-3 of 3
L. Elizabeth Budde
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies

Zhengyuan Dong, L. Elizabeth Budde, Elizabeth Oh, Szymon Szymura, Aaron Anderson, Marissa Del Real, Soung-chul Cha, Stephen J. Forman, Larry W. Kwak, Xiuli Wang
Journal: Blood Advances
Blood Adv (2024) 8 (15): 4066–4076.
https://doi.org/10.1182/bloodadvances.2024013195
Published: 2024
Includes: Supplemental data
Journal Articles

Interferon-γ blockade in CAR T-cell therapy–associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis

Clinical Trials & Observations
Michael Rainone, Dat Ngo, John H. Baird, L. Elizabeth Budde, Myo Htut, Ibrahim Aldoss, Vinod Pullarkat
Journal: Blood Advances
Blood Adv (2023) 7 (4): 533–536.
https://doi.org/10.1182/bloodadvances.2022008256
Published: 2023
Journal Articles

CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma

Clinical Trials & Observations
Tanya Siddiqi, Xiuli Wang, M. Suzette Blanchard, Jamie R. Wagner, Leslie L. Popplewell, L. Elizabeth Budde, Tracey L. Stiller, Mary C. Clark, Laura Lim, Vibhuti Vyas, Christine E. Brown, Stephen J. Forman
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4059–4063.
https://doi.org/10.1182/bloodadvances.2020004106
Published: 2021
Includes: Supplemental data